Skip to main content
. 2016 Aug 11;7(51):84375–84387. doi: 10.18632/oncotarget.11224

Figure 8. FOXC1 expression is associated with prognosis of melanoma.

Figure 8

A. There is significantly lower distant metastasis free survival rate among patients with high FOXC1 expression than patients with low FOXC1 expression from primary diagnosis date. B. There is significantly lower distant metastasis free survival rate among patients with high FOXC1 expression than patients with low FOXC1 expression from stage III diagnosis date. C. Schematic model for activating MST1R /PI3K/AKT pathway by FOXC1 overexpression and functional roles of FOXC1 in melanoma cells. *p <0.05.